ArticleTheranostics2017

Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast Cancer.

Yi-Chao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.